Genenta Science S.p.A.
GNTA · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $3 | $2 | $3 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $5 | $5 | $5 |
| Operating Income | -$3 | -$5 | -$5 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$4 | -$5 | -$4 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$4 | -$5 | -$4 | -$5 |
| % Margin | – | – | – | – |
| EPS | -0.2 | -0.27 | -0.22 | -0.27 |
| % Growth | 25.9% | -22.7% | 18.5% | – |
| EPS Diluted | -0.2 | -0.27 | -0.22 | -0.27 |
| Weighted Avg Shares Out | 19 | 18 | 18 | 18 |
| Weighted Avg Shares Out Dil | 19 | 18 | 18 | 18 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$5 | -$4 | -$5 |
| % Margin | – | – | – | – |